Galactico Corpo. (542802)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 8.33% shows some top-line expansion
• Price at ₹3.90 is at the 52-week high, indicating market interest
• P/E of 19.70 implies the company is still earning a small profit on an annual basis
• Small market cap of ₹58 Cr leaves room for a genuine operational turnaround

Concerns

• Profit growth fell 68.06% and the latest quarter reported net profit of ₹0 Cr
• ROE of 4.50% is far below the P/B of 3.71, suggesting overvaluation for the return generated
• Piotroski F-Score of 4/9 indicates weak financial health
• No dividend yield and unknown promoter holding/Debt-Equity create transparency and return concerns

AI Analysis

At ₹3.90, Galactico Corpo is being priced as if the future is bright, but the numbers tell me the present is weak. The market cap is ₹58 Cr, so this is a micro-cap, and micro-caps need even more certainty, not less. I am asked to pay 19.7 times earnings and 3.71 times book value, while the business earns only 4.50% on equity. That is a poor combination. A P/B of 3.71 with ROE of 4.50% means the company is not delivering an adequate return on the assets I am buying. Profit growth has fallen 68.06%, and the latest quarter shows sales of ₹6 Cr with net profit of zero. Sales growth of 8.33% appears to be evaporating at the bottom line. With no dividend yield, the investor must rely entirely on price appreciation, and at a 52-week high of ₹3.90, the easy optimism may already be in the price. The Piotroski F-score of 4 out of 9 signals weak financial health, and I do not have debt-to-equity or promoter holding data to assess risk and alignment. This is not a business with an obvious moat; diversified tells me it is a bit of this and that, but nothing dominant. Graham would ask: is there a margin of safety? Earnings yield is just over 5%, yet earnings are declining. Book value is ₹1.05, while the price is ₹3.90, so I am paying a large premium for mediocre returns. This may be an early turnaround story, but I need evidence of sustained profitability before I commit. For now, this is a speculation, not an investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer